SCHEMBL7791023

SCHEMBL7791023

COc1cc2nc(N)nc(-c3ccccc3I)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 7/20 0.57
CTSG P08311 1/20 0.55
KLK7 P49862 1/20 0.55
KLK14 Q9P0G3 1/20 0.55
KLK5 Q9Y337 1/20 0.55
DHFR P00374 2/20 0.49
WHR1 P49842 1/20 0.47
EGFR P00533 1/20 0.44
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 1/20 0.44
C1R P00736 1/20 0.44
ADORA1 P30542 1/20 0.43
ATM Q13315 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NQO2 P16083 1/20 0.41
PDPK1 O15530 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799233 0.85 ADORA2A (0.62) ADORA2ADHFRWHR1EGFRHSP90AA1
SCHEMBL7800422 0.84 ADORA2A (0.57) ADORA2AKLK7KLK14KLK5DHFR
SCHEMBL7585771 0.84 ADORA2A (0.57) ADORA2ADHFRWHR1EGFRHSP90AA1
SCHEMBL7791033 0.84 ADORA2A (0.61) ADORA2ADHFRWHR1EGFRHSP90AA1
SCHEMBL7790971 0.84 ADORA2A (0.57) ADORA2ADHFRWHR1EGFRHSP90AA1
SCHEMBL7799250 0.81 ADORA2A (0.53) ADORA2ADHFRWHR1EGFRHSP90AA1
SCHEMBL1257435 0.80 WHR1 (0.71) ADORA2ADHFRWHR1EGFRADORA1
SCHEMBL30759714 0.80 WHR1 (0.71) ADORA2ADHFRWHR1EGFRADORA1
SCHEMBL7800398 0.80 ADORA2A (0.55) ADORA2ACTSGKLK7KLK14KLK5
SCHEMBL7799239 0.79 ADORA2A (0.51) ADORA2ADHFRWHR1EGFRHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed